Vietnam Ovarian Cancer Drugs Market Analysis

Vietnam Ovarian Cancer Drugs Market Analysis


$ 3999

Vietnam ovarian cancer drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market is anticipated to develop as a result of the rising number of elderly women, rise in ovarian cancer cases, ease of use of new treatments and therapies, and increase in healthcare spending. Government spending is also accelerating the market's expansion. Some of the major key players in this market are F. Hoffmann-La Roche AG, Amgen Inc., Pfizer, Inc., Clovis Oncology, AstraZeneca, Abbvie Inc., etc.

ID: IN10VNPH355 CATEGORY: Pharmaceuticals GEOGRAPHY: Vietnam AUTHOR: Dr. Netal Patel

Buy Now

Vietnam Ovarian Cancer Drugs Market Analysis Summary

Vietnam Ovarian Cancer Drugs Market is valued at around $15.8 Mn in 2022 and is projected to reach $27.9 Mn by 2030, exhibiting a CAGR of 7.41% during the forecast period 2023-2030.

The leading cause of death for women with gynecological cancers is ovarian cancer. Additionally, it is the seventh most frequent reason for female fatalities overall. Most cases are first detected after the disease has advanced, which has negative effects. This suffering is made worse by the present screening tests' poor predictive value. The morbidity or mortality of this cancer has not been appreciably decreased by the most popular early detection techniques, which include a thorough gynecological examination, transvaginal ultrasound, and laboratory indicators like the cancer antigen-125 (CA-125) assay. The standard treatments for this gynecological cancer are surgery and platinum-based chemotherapy, however, during the past 10 years, anti-angiogenic bevacizumab and poly (ADP-ribose) polymerase (PARP) inhibitors have become more common. After the initial treatment, a high rate of recurrence has also been seen. These relapsed cases are known to have a lesser chance of recovery and a higher rate of treatment failures. Therefore, it is more important than ever to develop novel therapeutic approaches based on a deeper comprehension of the molecular traits of this malignancy. The ovarian cancer medicine market is anticipated to develop as a result of the rising number of elderly women, rise in ovarian cancer cases, ease of use of new treatments and therapies, and increase in healthcare spending. Government spending is also accelerating the market's expansion. The major key players in this market are F. Hoffmann-La Roche AG, Amgen Inc., Pfizer, Inc., Clovis Oncology, AstraZeneca, Abbvie Inc., Johnson & Johnson Services, Inc., Merck KGaA, Boehringer Ingelheim International GmbH, GlaxoSmithKline Plc.

Market Dynamics

Market Growth Drivers

The ovarian cancer medications market opportunity is created by growth and developments in the pharmaceutical sector for the production of ovarian cancer drugs due to a sizable pool of health-conscious customers. The market is expected to increase favorably as more ovarian cancer medications receive product approval from major players around the world.

Market Restraints

The development of the worldwide ovarian cancer market over the forecast period may be constrained by a lack of skilled experts who are unaware of the available treatment options.

Competitive Landscape

Key Players

  • F. Hoffmann-La Roche AG
  • Amgen Inc.
  • Pfizer, Inc.
  • Clovis Oncology
  • AstraZeneca
  • Abbvie Inc.
  • Johnson & Johnson Services, Inc.
  • Merck KGaA
  • Boehringer Ingelheim International GmbH
  • GlaxoSmithKline Plc.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Vietnam Ovarian Cancer Drugs Market Segmentation

By Treatment Type

  • Chemotherapy
  • Targeted Therapy
  • Others

By Route of Administration

  • Oral
  • Parenteral
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online pharmacies

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.​

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

  • Analyzing historical proprietary data collected from multiple projects.
  • Regularly updating our existing data sets with new findings and trends.
  • Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

  • Searching through academic conferences, published research, citations, and social media platforms
  • Collecting and compiling diverse data to build a comprehensive and detailed database
  • Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

  • Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
  • Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
  • Continuously refreshing our database to ensure that the information remains current and reliable.
  • Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

  • Merging historical data from secondary research with real-time data from primary research.
  • Conducting thorough data validation and cleansing to remove inconsistencies and errors.
  • Organizing data into a structured format that is easily accessible and usable for various applications.
  • Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


Last updated on: 27 February 2024
Updated by: Anish Swaminathan

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up